{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:24:19Z","timestamp":1762899859799,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.beha.2020.101146","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:03:09Z","timestamp":1579021389000},"page":"101146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tracking myeloma tumor DNA in peripheral blood"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5340-1818","authenticated-orcid":false,"given":"Johannes M.","family":"Waldschmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushara","family":"Vijaykumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Knoechel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens G.","family":"Lohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2020.101146_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2012.15","article-title":"Latest advances and current challenges in the treatment of multiple myeloma","volume":"9","author":"Mahindra","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beha.2020.101146_bib2","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"Lohr","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2020.101146_bib5","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"Bolli","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101146_bib6","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1200\/JCO.2005.05.021","article-title":"Molecular pathogenesis and a consequent classification of multiple myeloma","volume":"23","author":"Bergsagel","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2020.101146_bib7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.beha.2020.101146_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2020.101146_bib9","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.beha.2020.101146_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/2159-8290.CD-13-0014","article-title":"Targeting the BRAF V600E mutation in multiple myeloma","volume":"3","author":"Andrulis","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2020.101146_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","article-title":"High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2020.101146_bib12","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1182\/blood-2015-12-686782","article-title":"Spatially divergent clonal evolution in multiple myeloma: overcoming resistance to BRAF inhibition","volume":"127","author":"Raab","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101146_bib14","first-page":"241","article-title":"[Not available]","volume":"142","author":"Mandel","year":"1948","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1016\/j.beha.2020.101146_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2017-03-735639","article-title":"High-throughput sequencing for noninvasive disease detection in hematologic malignancies","volume":"130","author":"Scherer","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2020.101146_bib17","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.beha.2020.101146_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00965-y","article-title":"Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors","volume":"8","author":"Adalsteinsson","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101146_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000702","article-title":"Development of personalized tumor biomarkers using massively parallel sequencing","volume":"2","author":"Leary","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2020.101146_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.beha.2020.101146_bib21","doi-asserted-by":"crossref","first-page":"15086","DOI":"10.1038\/ncomms15086","article-title":"Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates","volume":"8","author":"Kis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101146_bib22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/leu.2016.366","article-title":"Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma","volume":"31","author":"Mithraprabhu","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101146_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071858","article-title":"Circulating tumour DNA analysis for tumour genome characterisation and monitoring disease burden in extramedullary multiple myeloma","volume":"19","author":"Mithraprabhu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beha.2020.101146_bib24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41375-019-0469-x","article-title":"Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients","volume":"33","author":"Mithraprabhu","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101146_bib25","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41467-018-04001-5","article-title":"Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma","volume":"9","author":"Manier","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2020.101146_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3324\/haematol.2016.161414","article-title":"Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA","volume":"102","author":"Oberle","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101146_bib27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/s41375-018-0115-z","article-title":"Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing","volume":"32","author":"Guo","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101146_bib28","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.3324\/haematol.2017.184358","article-title":"Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias","volume":"103","author":"Gerber","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101146_bib29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jmoldx.2018.07.006","article-title":"Noninvasive molecular monitoring in multiple myeloma patients using cell-free tumor DNA: a pilot study","volume":"20","author":"Biancon","year":"2018","journal-title":"J Mol Diagn JMD"},{"key":"10.1016\/j.beha.2020.101146_bib30","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3324\/haematol.2016.160564","article-title":"Monitoring multiple myeloma by quantification of recurrent mutations in serum","volume":"102","author":"Rustad","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101146_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jmoldx.2017.06.004","article-title":"Comparison of blood collection tubes from three different manufacturers for the collection of cell-free DNA for liquid biopsy mutation testing","volume":"19","author":"Alidousty","year":"2017","journal-title":"J Mol Diagn JMD"},{"key":"10.1016\/j.beha.2020.101146_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4939-7865-6_9","article-title":"Analysis of circulating tumor DNA","volume":"1792","author":"Mithraprabhu","year":"2018","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.beha.2020.101146_bib33","first-page":"646","article-title":"Free DNA in the serum of cancer patients and the effect of therapy","volume":"37","author":"Leon","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2020.101146_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMc1816154","article-title":"Cell-free DNA analysis in cancer","volume":"380","author":"Corcoran","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2020.101146_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/genes10010032","article-title":"Epigenetic biomarkers in cell-free DNA and applications in liquid biopsy","volume":"10","author":"Gai","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.beha.2020.101146_bib36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/infdis\/jis032","article-title":"CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA","volume":"205","author":"Shamay","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.beha.2020.101146_bib37","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1038\/bcj.2016.1","article-title":"Panel sequencing for clinically oriented variant screening and copy number detection in 142 untreated multiple myeloma patients","volume":"6","author":"Kortuem","year":"2016","journal-title":"Blood Canc J"},{"key":"10.1016\/j.beha.2020.101146_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00277-015-2344-9","article-title":"Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)","volume":"94","author":"Kort\u00fcm","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2020.101146_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.12478","article-title":"Clinical course and prognosis of non-secretory multiple myeloma","author":"Chawla","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2020.101146_bib40","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.2147\/OTT.S122241","article-title":"Non-secretory multiple myeloma: from biology to clinical management","volume":"9","author":"Dupuis","year":"2016","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.beha.2020.101146_bib41","article-title":"High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma","volume":"7","author":"Mills","year":"2017","journal-title":"Blood Canc J"},{"key":"10.1016\/j.beha.2020.101146_bib42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2011-07-370460","article-title":"High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma","volume":"119","author":"Paiva","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib43","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores-Montero","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2020.101146_bib44","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-07-590166","article-title":"Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction","volume":"125","author":"Rawstron","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7037","article-title":"Genetic interrogation of circulating multiple myeloma cells at single-cell resolution","volume":"8","author":"Lohr","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2020.101146_bib46","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/bloodadvances.2018025197","article-title":"Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow","volume":"2","author":"Mazzotti","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2020.101146_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-016-0336-4","article-title":"High applicability of ASO-RQPCR for detection of minimal residual disease in multiple myeloma by entirely patient-specific primers\/probes","volume":"9","author":"Bai","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.beha.2020.101146_bib48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm.3841","article-title":"Studying clonal dynamics in response to cancer therapy using high-complexity barcoding","volume":"21","author":"Bhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2020.101146_bib49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.12688\/f1000research.13440.1","article-title":"Can circulating tumor DNA be used for direct and early stage cancer detection?","volume":"6","author":"Diamandis","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.beha.2020.101146_bib50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.beha.2020.101146_bib51","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2020.101146_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.celrep.2017.03.025","article-title":"The mutational landscape of circulating tumor cells in multiple myeloma","volume":"19","author":"Mishima","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.beha.2020.101146_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2020.101146_bib55","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jmoldx.2015.06.006","article-title":"Aberrant levels of miRNAs in bone marrow microenvironment and peripheral blood of myeloma patients and disease progression","volume":"17","author":"Wang","year":"2015","journal-title":"J Mol Diagn JMD"},{"key":"10.1016\/j.beha.2020.101146_bib56","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.18632\/oncotarget.2761","article-title":"A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma","volume":"6","author":"Navarro","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.beha.2020.101146_bib57","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-12-2043","article-title":"Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia","volume":"19","author":"Lionetti","year":"2013","journal-title":"Clin Canc Res Off J Am Assoc Canc Res"},{"key":"10.1016\/j.beha.2020.101146_bib58","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1182\/blood-2013-06-510453","article-title":"Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile","volume":"122","author":"Paiva","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2020.101146_bib59","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/10428194.2016.1266621","article-title":"Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry","volume":"58","author":"Baughn","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.beha.2020.101146_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.seminhematol.2018.02.010","article-title":"Comprehensive characterization of circulating and bone marrow-derived multiple myeloma cells at minimal residual disease","volume":"55","author":"Waldschmidt","year":"2018","journal-title":"Semin Hematol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692620300074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:05:22Z","timestamp":1761498322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692620300074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1521692620300074"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2020.101146","relation":{},"ISSN":["1521-6926"],"issn-type":[{"type":"print","value":"1521-6926"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tracking myeloma tumor DNA in peripheral blood","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2020.101146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101146"}}